首页
登录
职称英语
Informed public debate critical to future of genomic medicine
Informed public debate critical to future of genomic medicine
游客
2023-07-17
58
管理
问题
Informed public debate critical to future of genomic medicine
Just mentioning "stem-cell research" or "genomic medicine" can open a floodgate of beliefs, concerns and, misinformation. Opinions are varied, mixed with fact and fiction, but one thing is clear: Open dialogue among researchers, teachers and the general public must continue as we struggle to define the relationship between our societal values and lifesciences research.
When the University of Washington .and the National Human Genome Research Institute hosted a community genetics forum last spring, questions abounded from the standing-room-only crowd about the implications of genetic research.
When is information about genetic health risks most helpful? Should genetic testing results be part of medical records and how would the results be used potentially by insurance companies? How can genetic testing benefit the criminal-justice system, such as establishings guilt or innocence using DNA testing,
The Human Genome Project will lead to amazing advances in medical science that will result in earlier diagnosis, more-targeted treatment, and a dramatic improvement in our ability to prevent terrible diseases. Genomic medicine will mean more personalized medicine tailored to the individual.
But these advances also carry inherent risks.
The obvious benefits of "personalized medicine" —use of genetic tests to guide preventive care and better drug prescribing—are counterbalanced by the possibility that such tests could lead to discrimination by insurers or employers. And, since genetic risk is often only one of the contributing factors to disease, overemphasis on personalized medicine could burden our health-care system with genetic tests of little or no benefit.
For example, smoking, diet and exercise play major roles in the risk of diabetes and heart disease. Identification of a genetic risk for these diseases can provide specific information for more-effective preventive care, but should not detract from pursuit of a healthy lifestyle.
The greatest health benefits of genomic research likely will come from insights into the basic biology of health and disease. This will ultimately lead to improved prevention and treatment—often without any need for genetic testing—for many diseases. The outcome from this research can be "precision medcine" —a morecost-effective approach to providing high-quality care. Thus, genomic medicine has the potential to improve the value of health care.
An example of the potential of genomic medicine to improve quality and reduce cost is the work of UW researchers Mark Rieder, Allan Rettie and Debbie Nickerson. They recently reported the discovery of a genetic method for accurately determining the proper dosage of a common blood-thinning drug, warfarin, which often produces adverse side effects because of its highly variable activity in patients.
Millions of people worldwide take worldwide to prevent stroke and blood clots, yet require expensive, constant testing from their physician to ensure proper dosage. These scientists’ findings illustrate how the powerful DNA analysis tools of the Human Genome Project are leading to a new era of tailoring drugs and therapies to an individual’s genome. Genomic medicine can lead to more-precise, personalized and cost- effective health care.
Medical advances always involve risk of harm, and genomic medicine is no exception. While technical issues require scientific research, we believe the challenges posed by genetic testing are far too critical to be left to the deliberation of scientists alone.
All members of society should have the opportunity to engage in collaborative discussion about the benefits and harms of genetic testing. Informed public discussion is vital to continue advances that hold so much promise for improving the value of health care.
Both educational resources and major organizational efforts will be needed to create opportunities for open discussion. But the most important resources are people’s time and their willingness to invest it in these discussions.
Researchers, teachers and the media have an obligation to create opportunities for sharing accurate, well-balanced information about potential uses of genomic technology. [br] China took part in the Human Genome Project in 1993.
选项
A、Y
B、N
C、NG
答案
C
解析
文中外未讲到中国加入人类基因组工程研究的情况
转载请注明原文地址:http://tihaiku.com/zcyy/2846309.html
相关试题推荐
Infuturetradethekeydevelopmenttowatchistherelationshipbetweenthe
ChicagoPublicSchoolsofficialsaregivingthepublicanearlylookatthe
ChicagoPublicSchoolsofficialsaregivingthepublicanearlylookatthe
ChicagoPublicSchoolsofficialsaregivingthepublicanearlylookatthe
ChicagoPublicSchoolsofficialsaregivingthepublicanearlylookatthe
ChicagoPublicSchoolsofficialsaregivingthepublicanearlylookatthe
ChicagoPublicSchoolsofficialsaregivingthepublicanearlylookatthe
TheArtofPublicSpeakingIfyouweretotape-reco
TheArtofPublicSpeakingIfyouweretotape-reco
TheArtofPublicSpeakingIfyouweretotape-reco
随机试题
Lookatthenotesbelow.Someinformationismissing.Youwillhearareporton
【B1】[br]【B7】A、forB、byC、atD、fromB此题为语篇结构辨析题。联系上下文,此处原文意为:但当时他63岁了……。B.by到…
喷口或喷嘴射入无限广阔的空间,并且射流出口的雷诺数较大,则成为紊流自由射流,其主
口服治疗量维生素D治疗佝偻病的疗程是()A.用至痊愈 B.用至3岁 C.
纽约商品交易所的石油合约以()桶为最小交易单位,芝加哥商品交易所的小麦以()
Thechangeinthatvillagewasmiraculou
我国药品不良反应申报采取的是A.集中监测 B.记录联结 C.自愿呈报 D.
变压器有载分接开关滤油装置的工作方式为()。正常运行时一般采用联动滤油方式$
药品零售企业《药品经营许可证》经营范围项下需要明确冷藏、冷冻才能经营的肽类激素类
患者,女,16岁,体健。主诉双侧后牙咀嚼无力。临床检查见双侧下第一磨牙及下切牙袋
最新回复
(
0
)